论文部分内容阅读
目的:探讨临床对小儿肺炎患者实施静脉滴注盐酸氨臭素治疗的可行性。方法:随机将60例患者分为对照组和观察组,对照组实施常规基础治疗,观察组在常规治疗的基础上实施静脉滴注盐酸氨溴索治疗,对比分析两组患者治疗效果。结果:观察组治疗的总有效率为93.33%,对照组为80%,两组比较P<0.05,差异有统计学意义。观察组患者治疗后肺部湿罗音消失时间、每天吸痰次数减少时间、退热时间等明显少于对照组,两组比较P<0.05,差异有统计学意义。观察组患者不良反应发生率为10%,对照组为16.66%,两组不良反应比较P>0.05,差异无统计学意义。结论:对小儿肺炎患者实施静脉滴注盐酸氨溴索治疗不仅效果显著,而且不良反应少,安全性及可行性高,值得临床推广使用。
Objective: To investigate the clinical feasibility of intravenous drip infusion of trimethoprim in children with pneumonia. Methods: Sixty patients were randomly divided into control group and observation group. The control group was given routine basic treatment. The observation group was given intravenous infusion of ambroxol on the basis of routine treatment. The therapeutic effect was compared between the two groups. Results: The total effective rate of observation group was 93.33%, control group was 80%, P <0.05, the difference was statistically significant. Observation group patients after treatment of lung wet rales disappear time, the number of sputum per day to reduce the time, fever and other significantly less than the control group, the two groups compared P <0.05, the difference was statistically significant. The incidence of adverse reactions in the observation group was 10%, while that in the control group was 16.66%. There was no significant difference in adverse reactions between the two groups (P> 0.05). Conclusion: The application of intravenous infusion of ambroxol hydrochloride in children with pneumonia is not only effective, but also has less adverse reactions, high safety and feasibility, and is worthy of clinical application.